Evidence map›Paper›PMID 28680291›Full record

ArticleCurrent oncology (Toronto, Ont.)2017

Patterns of failure in anaplastic and differentiated thyroid carcinoma treated with intensity-modulated radiotherapy.

H Vulpe, J Y Y Kwan, A McNiven, J D Brierley, R Tsang, B Chan, D P Goldstein, L W Le, A Hope, M Giuliani

Open access · goldAbstract read
In one paragraph

Article in Current oncology (Toronto, Ont.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Guideline
  2. Patterns of loco-regional progression and patient outcomes after definitive-dose radiation therapy for anaplastic thyroid cancer.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology · 2025
    Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

H VulpeDepartment of Radiation Oncology, Princess Margaret Cancer Centre.
J Y Y KwanDepartment of Radiation Oncology, Princess Margaret Cancer Centre.
A McNivenDepartment of Radiation Oncology, Princess Margaret Cancer Centre.
J D BrierleyDepartment of Radiation Oncology, Princess Margaret Cancer Centre.
R TsangDepartment of Radiation Oncology, Princess Margaret Cancer Centre.
B ChanRadiation Medicine Program, Princess Margaret Cancer Centre.
D P GoldsteinDepartment of Otolaryngology-Head and Neck Surgery; and.
L W LeDepartment of Biostatistics, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON.
A HopeDepartment of Radiation Oncology, Princess Margaret Cancer Centre.
M GiulianiDepartment of Radiation Oncology, Princess Margaret Cancer Centre.
Princess Margaret Cancer Centre · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe radiotherapy (rt) volumes in anaplastic (atc) and differentiated thyroid carcinoma (dtc) are controversial.

methodsWe retrospectively examined the patterns of failure after postoperative intensity-modulated rt for atc and dtc. Computed tomography images were rigidly registered with the original rt plans. Recurrences were considered in-field if more than 95% of the recurrence volume received 95% of the prescribed dose, out-of-field if less than 20% received 95% of the dose, and marginal otherwise.

resultsOf 30 dtc patients, 4 developed regional recurrence: 1 being in-field (level iii), and 3 being out-of-field (all level ii). Of 5 atc patients, all 5 recurred at 7 sites: 2 recurrences being local, and 5 being regional [2 marginal (intramuscular to the digastric and sternocleidomastoid), 3 out-of-field (retropharyngeal, soft tissues near the manubrium, and lateral to the sternocleidomastoid)].

conclusionsIn dtc, locoregional recurrence is unusual after rt. Out-of-field dtc recurrences infrequently occurred in level ii. Enlarged treatment volumes to level ii must be balanced against a potentially greater risk of toxicity.

Indexed as

anaplastic thyroid carcinomapapillary carcinomaradiotherapyrecurrenceThyroid neoplasms

Identifiers

PMID28680291
PMCPMC5486396
OpenAlexW2725898486

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.